Terns Pharmaceuticals Inc (NASDAQ: TERN): Reassessing Prospects
Terns Pharmaceuticals Inc (TERN) concluded trading on Wednesday at a closing price of $4.18, with 2.68 million shares of worth about $11.2 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -49.82% during that period and on January 29, 2025 the price saw a […]
